YUM
59
-3
EA
46
2
MCD
46
4
AVY
44
-2
NEE
67
13
MDT
50
-2
AME
50
-4
ITW
42
-3
APA
38
-6
A
57
-5
CSCO
58
-2
RIG
11
-5
MTCH
55
-2
ICE
55
3
CI
52
10
NWL
45
-3
ADM
56
-3
GILD
54
4
APD
52
-2
HBAN
59
-3
YUM
59
-3
EA
46
2
MCD
46
4
AVY
44
-2
NEE
67
13
MDT
50
-2
AME
50
-4
ITW
42
-3
APA
38
-6
A
57
-5
CSCO
58
-2
RIG
11
-5
MTCH
55
-2
ICE
55
3
CI
52
10
NWL
45
-3
ADM
56
-3
GILD
54
4
APD
52
-2
HBAN
59
-3
Financhill
Back

Nuveen Select Tax Free Income Portfolio Vs. Akero Therapeutics Industry Stock Comparison

Sell
43

NXP
Nuveen Select Tax Free Income Portfolio

Last Price:
$13.96
Seasonality Move:
-0.27%
Sell
44

AKRO
Akero Therapeutics

Last Price:
$52.72
Seasonality Move:
45.38%
Sell
43
Nuveen Select Tax Free Income Portfolio (NXP) is a Sell

Is Nuveen Select Tax Free Income Portfolio a Buy, Sell or Hold?

  • The current Nuveen Select Tax Free Income Portfolio [NXP] share price is $13.98. The Score for NXP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • NXP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $52.73. The Score for AKRO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NXP Stock Price Chart

What is Nuveen Select Tax Free Income Portfolio's stock price today?

  • The Nuveen Select Tax Free Income Portfolio share price today is $13.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NXP is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $52.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.

NXP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.45 Buy
Relative Strength Index (14 RSI): 48.16 Sell
Chaikin Money Flow: 76276 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.95 - 14.03) Sell
Bollinger Bands (100): (13.86 - 14.42) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.37 Buy
Relative Strength Index (14 RSI): 53.6 Buy
Chaikin Money Flow: 120856 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.86 - 55.26) Sell
Bollinger Bands (100): (40.15 - 52.05) Buy

NXP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14 Sell
20-day SMA: 13.99 Sell
50-day SMA: 14.03 Sell
200-day SMA: 14.5 Sell
8-day EMA: 10 Buy
20-day EMA: 5.5 Buy
50-day EMA: 2.53 Buy
200-day EMA: 0.68 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.62 Buy
20-day SMA: 53.45 Sell
50-day SMA: 49.34 Buy
200-day SMA: 39.34 Buy
8-day EMA: 52.09 Buy
20-day EMA: 52.29 Buy
50-day EMA: 49.9 Buy
200-day EMA: 41.1 Buy

Nuveen Select Tax Free Income Portfolio Earnings Growth & NXP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

Nuveen Select Tax Free Income Portfolio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):